Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform

Journal:
ACS Nano
Published:
DOI:
10.1021/acsnano.5c10202
Affiliations:
4
Authors:
8
Go to article
Institutions Authors Share
Renji Hospital, SJTU, China
3.500000
 0.44
Shanghai Pulmonary Hospital, China
3.500000
 0.44
Immunopathologie et Chimie Thérapeutique, IBMC, France
1.000000
 0.13
Interested in Oncology and Carcinogenesis?